Treatment of Sezary syndrome with combination romidepsin and tofacitinib: A case report

Treatment of Sezary syndrome with combination romidepsin and tofacitinib: A case report

Saved in:

Bibliographic Details
Main Authors:	Sara Suhl, BS, Brigit Lapolla, BS, Alexander Kaminsky, BS, Larisa J. Geskin, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	JAAD Case Reports
Subjects:	case report CTCL cutaneous T-cell lymphoma HDAC histone deacetylase inhibitor JAK
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624004478
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HDAC10 and its implications in Sézary syndrome pathogenesis
by: Monika Pieniawska, et al.
Published: (2025-01-01)

The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
by: Antonio Curcio, et al.
Published: (2024-05-01)

Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity
by: Sadaf Kalsum, et al.
Published: (2024-11-01)

Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors
by: Julia Krushkal, et al.
Published: (2024-12-01)

Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
by: Wanli Zhang, et al.
Published: (2025-02-01)

Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
by: K.V. Woan, et al.
Published: (2015-08-01)

Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat
by: Tamara Zenz, et al.
Published: (2025-02-01)

HDAC1 and HDAC2 Are Involved in Influenza A Virus-Induced Nuclear Translocation of Ectopically Expressed STAT3-GFP
by: Jessica Leong, et al.
Published: (2024-12-01)

Circadian rhythms in haematological malignancies: therapeutic potential and personalised interventions
by: Marjan Motiei, et al.
Published: (2024-12-01)

Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity
by: Zhengshui Xu, et al.
Published: (2024-12-01)

THE TREATMENT OF ADVANCED-STAGE MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A HEMATOLOGIST'S POINT OF VIEW.
by: Antonio Giordano, et al.
Published: (2022-02-01)

Extensive polymorphic eruption and lymphocytosis in a 56‐year‐old male—A difficult diagnosis!
by: Berbie Byrne, et al.
Published: (2024-12-01)

Novel histone deacetylase-5 inhibitor T2943 exerts an anti-depressive effect in mice by enhancing GRID1 expression
by: Juan Du, et al.
Published: (2025-02-01)

Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
by: Lina U. Ivert, et al.
Published: (2024-12-01)

Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
by: Lina U. Ivert, et al.
Published: (2024-08-01)

Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy
by: Dan-Feng Cao, et al.
Published: (2024-11-01)

Synthesis and biological evaluation of ortho-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases
by: Kai-Cheng Hsu, et al.
Published: (2024-12-01)

dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation
by: Mohammad Mijanur Rahman, et al.
Published: (2024-12-01)

Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation
by: Xiao Qiao, et al.
Published: (2024-12-01)

Multi-Target Inhibitor CUDC-101 Impairs DNA Damage Repair and Enhances Radiation Response in Triple-Negative Breast Cell Line
by: Elsie Neo Seane, et al.
Published: (2024-11-01)

Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids
by: Arun Sridhar, et al.
Published: (2025-01-01)

Research progress on tofacitinib in the treatment of chronic actinic dermatitis
by: WU Hui, et al.
Published: (2024-12-01)

INDUCTION OF ACETYLATION PROCESSES IN ANIMALS WITH SEROTONERGIC NEURON DYSFUNCTION REVERSES THEIR CAPABILITY OF LONG-TERM MEMORY FORMATION
by: O. V. Vorobiova, et al.
Published: (2015-01-01)

Neuronal Differentiation of Human Glioma Cells Induced by Parthenolide Under In Vitro Conditions
by: Zhaoqi Tang, et al.
Published: (2024-11-01)

A photodistributed rash in a patient on apixaban
by: Benjamin Donald Henson, BS, et al.
Published: (2025-01-01)

Identification of Potential Inhibitors of Histone Deacetylase 6 Through Virtual Screening and Molecular Dynamics Simulation Approach: Implications in Neurodegenerative Diseases
by: Anas Shamsi, et al.
Published: (2024-11-01)

Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient
by: Pier Luigi Zinzani, et al.
Published: (2020-06-01)

Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
by: Francine Foss, et al.
Published: (2025-12-01)

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications
by: Xiaohong Duan, et al.
Published: (2024-11-01)

ROLE OF THE MODULATORY MEDIATOR SEROTONIN IN THE INDUCTION OF EPIGENETIC PROCESSES DURING LONG TERM MEMORY FORMATION IN HELIX
by: L. N. Grinkevich, et al.
Published: (2015-01-01)

Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the MLL-AF4 gene: a case report and literature review
by: Xuelian Jin, et al.
Published: (2025-01-01)

Modulation of biological activities in adipose derived stem cells by histone deacetylation
by: Sallam Abdallah, et al.
Published: (2025-01-01)

Evaluating biomarkers in canine cytotoxic interface dermatitis reactions to account for clinical and histopathological similarities and differences
by: Shriya Kannan, et al.
Published: (2025-01-01)

A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma
by: Anshun Wu, et al.
Published: (2024-12-01)

Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
by: Anna Roppelt, et al.
Published: (2025-01-01)

Expression and significance of HDAC5 in oral squamous cell carcinoma
by: HE Fenjun, LIN Fen, CHEN Xueying
Published: (2024-12-01)

A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL
by: Xueying Wang, et al.
Published: (2024-12-01)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
by: Alexis Ogdie, et al.
Published: (2024-09-01)

P-glycoprotein and/or Histone Deacetylase 2 Regulates Steroid Responsiveness in Childhood Nephrotic Syndrome
by: Harshit Singh, et al.
Published: (2020-01-01)

Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib
by: Frederik S. Gillesberg, et al.
Published: (2025-01-01)